Global Allergy Rhinitis Drugs Market 2024-2028
The allergy rhinitis drugs market is forecasted to grow by USD 3.17 bn during 2023-2028, accelerating at a CAGR of 3.92% during the forecast period. The report on the allergy rhinitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of allergy rhinitis, high unmet medical needs, and technological advances in allergy rhinitis diagnostics.
Technavio's allergy rhinitis drugs market is segmented as below:
By Distribution Channel
- Offline
- Online
- Antihistamines
- Intranasal corticosteroids
- Immunotherapies
- Others
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the allergy rhinitis drugs market covers the following areas:
- Allergy rhinitis drugs market sizing
- Allergy rhinitis drugs market forecast
- Allergy rhinitis drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
- 1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary - Chart on Market Overview
- Exhibit 02: Executive Summary - Data Table on Market Overview
- Exhibit 03: Executive Summary - Chart on Global Market Characteristics
- Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
- Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
- Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary - Chart on Incremental Growth
- Exhibit 08: Executive Summary - Data Table on Incremental Growth
- Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
- 2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
- 3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- 4 Historic Market Size
- 4.1 Global allergy rhinitis drugs market 2018 - 2022
- Exhibit 18: Historic Market Size - Data Table on global allergy rhinitis drugs market 2018 - 2022 ($ billion)
- 4.2 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
- 4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
- 5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
- 6 Market Segmentation by Distribution Channel
- 6.1 Market segments
- Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
- 6.2 Comparison by Distribution Channel
- Exhibit 32: Chart on Comparison by Distribution Channel
- Exhibit 33: Data Table on Comparison by Distribution Channel
- 6.3 Offline - Market size and forecast 2023-2028
- Exhibit 34: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Offline - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
- 6.4 Online - Market size and forecast 2023-2028
- Exhibit 38: Chart on Online - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Online - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Online - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Distribution Channel
- Exhibit 42: Market opportunity by Distribution Channel ($ billion)
- Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ billion)
- 7 Market Segmentation by Product
- 7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
- 7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product
- 7.3 Antihistamines - Market size and forecast 2023-2028
- Exhibit 48: Chart on Antihistamines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 49: Data Table on Antihistamines - Market size and forecast 2023-2028 ($ billion)
- Exhibit 50: Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
- 7.4 Intranasal corticosteroids - Market size and forecast 2023-2028
- Exhibit 52: Chart on Intranasal corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Intranasal corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Intranasal corticosteroids - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Intranasal corticosteroids - Year-over-year growth 2023-2028 (%)
- 7.5 Immunotherapies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Immunotherapies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Immunotherapies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Immunotherapies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Immunotherapies - Year-over-year growth 2023-2028 (%)
- 7.6 Others - Market size and forecast 2023-2028
- Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
- 7.7 Market opportunity by Product
- Exhibit 64: Market opportunity by Product ($ billion)
- Exhibit 65: Data Table on Market opportunity by Product ($ billion)
- 8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.10 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.11 France - Market size and forecast 2023-2028
- Exhibit 103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on France - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity By Geographical Landscape
- Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
- Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
- 10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
- 11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
- 12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 113: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification
- 12.3 ALK Abello AS
- Exhibit 115: ALK Abello AS - Overview
- Exhibit 116: ALK Abello AS - Product / Service
- Exhibit 117: ALK Abello AS - Key offerings
- 12.4 Apotex Inc.
- Exhibit 118: Apotex Inc. - Overview
- Exhibit 119: Apotex Inc. - Product / Service
- Exhibit 120: Apotex Inc. - Key offerings
- 12.5 Bayer AG
- Exhibit 121: Bayer AG - Overview
- Exhibit 122: Bayer AG - Business segments
- Exhibit 123: Bayer AG - Key news
- Exhibit 124: Bayer AG - Key offerings
- Exhibit 125: Bayer AG - Segment focus
- 12.6 Dr Reddys Laboratories Ltd.
- Exhibit 126: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 127: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 128: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 129: Dr Reddys Laboratories Ltd. - Segment focus
- 12.7 Faes Farma SA
- Exhibit 130: Faes Farma SA - Overview
- Exhibit 131: Faes Farma SA - Product / Service
- Exhibit 132: Faes Farma SA - Key offerings
- 12.8 GlaxoSmithKline Plc
- Exhibit 133: GlaxoSmithKline Plc - Overview
- Exhibit 134: GlaxoSmithKline Plc - Business segments
- Exhibit 135: GlaxoSmithKline Plc - Key news
- Exhibit 136: GlaxoSmithKline Plc - Key offerings
- Exhibit 137: GlaxoSmithKline Plc - Segment focus
- 12.9 Glenmark Pharmaceuticals Ltd.
- Exhibit 138: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 139: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 140: Glenmark Pharmaceuticals Ltd. - Key offerings
- 12.10 Haleon Plc
- Exhibit 141: Haleon Plc - Overview
- Exhibit 142: Haleon Plc - Business segments
- Exhibit 143: Haleon Plc - Key offerings
- Exhibit 144: Haleon Plc - Segment focus
- 12.11 Hikma Pharmaceuticals Plc
- Exhibit 145: Hikma Pharmaceuticals Plc - Overview
- Exhibit 146: Hikma Pharmaceuticals Plc - Business segments
- Exhibit 147: Hikma Pharmaceuticals Plc - Key offerings
- Exhibit 148: Hikma Pharmaceuticals Plc - Segment focus
- 12.12 Merck and Co. Inc.
- Exhibit 149: Merck and Co. Inc. - Overview
- Exhibit 150: Merck and Co. Inc. - Business segments
- Exhibit 151: Merck and Co. Inc. - Key news
- Exhibit 152: Merck and Co. Inc. - Key offerings
- Exhibit 153: Merck and Co. Inc. - Segment focus
- 12.13 Mitsubishi Chemical Group Corp.
- Exhibit 154: Mitsubishi Chemical Group Corp. - Overview
- Exhibit 155: Mitsubishi Chemical Group Corp. - Business segments
- Exhibit 156: Mitsubishi Chemical Group Corp. - Key offerings
- Exhibit 157: Mitsubishi Chemical Group Corp. - Segment focus
- 12.14 Novartis AG
- Exhibit 158: Novartis AG - Overview
- Exhibit 159: Novartis AG - Business segments
- Exhibit 160: Novartis AG - Key offerings
- Exhibit 161: Novartis AG - Segment focus
- 12.15 Sanofi SA
- Exhibit 162: Sanofi SA - Overview
- Exhibit 163: Sanofi SA - Business segments
- Exhibit 164: Sanofi SA - Key news
- Exhibit 165: Sanofi SA - Key offerings
- Exhibit 166: Sanofi SA - Segment focus
- 12.16 Stallergenes Greer Ltd.
- Exhibit 167: Stallergenes Greer Ltd. - Overview
- Exhibit 168: Stallergenes Greer Ltd. - Product / Service
- Exhibit 169: Stallergenes Greer Ltd. - Key offerings
- 12.17 Viatris Inc.
- Exhibit 170: Viatris Inc. - Overview
- Exhibit 171: Viatris Inc. - Business segments
- Exhibit 172: Viatris Inc. - Key news
- Exhibit 173: Viatris Inc. - Key offerings
- Exhibit 174: Viatris Inc. - Segment focus
- 13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 175: Inclusions checklist
- Exhibit 176: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 177: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 178: Research methodology
- Exhibit 179: Validation techniques employed for market sizing
- Exhibit 180: Information sources
- 13.5 List of abbreviations
- Exhibit 181: List of abbreviations
- Exhibits:
- Exhibits1: Executive Summary - Chart on Market Overview
- Exhibits2: Executive Summary - Data Table on Market Overview
- Exhibits3: Executive Summary - Chart on Global Market Characteristics
- Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
- Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
- Exhibits6: Executive Summary - Chart on Market Segmentation by Product
- Exhibits7: Executive Summary - Chart on Incremental Growth
- Exhibits8: Executive Summary - Data Table on Incremental Growth
- Exhibits9: Executive Summary - Chart on Vendor Market Positioning
- Exhibits10: Parent market
- Exhibits11: Market Characteristics
- Exhibits12: Offerings of vendors included in the market definition
- Exhibits13: Market segments
- Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibits18: Historic Market Size - Data Table on global allergy rhinitis drugs market 2018 - 2022 ($ billion)
- Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
- Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
- Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
- Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
- Exhibits23: Five forces analysis - Comparison between 2023 and 2028
- Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
- Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
- Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
- Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
- Exhibits29: Chart on Market condition - Five forces 2023 and 2028
- Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
- Exhibits32: Chart on Comparison by Distribution Channel
- Exhibits33: Data Table on Comparison by Distribution Channel
- Exhibits34: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
- Exhibits35: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
- Exhibits36: Chart on Offline - Year-over-year growth 2023-2028 (%)
- Exhibits37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
- Exhibits38: Chart on Online - Market size and forecast 2023-2028 ($ billion)
- Exhibits39: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
- Exhibits40: Chart on Online - Year-over-year growth 2023-2028 (%)
- Exhibits41: Data Table on Online - Year-over-year growth 2023-2028 (%)
- Exhibits42: Market opportunity by Distribution Channel ($ billion)
- Exhibits43: Data Table on Market opportunity by Distribution Channel ($ billion)
- Exhibits44: Chart on Product - Market share 2023-2028 (%)
- Exhibits45: Data Table on Product - Market share 2023-2028 (%)
- Exhibits46: Chart on Comparison by Product
- Exhibits47: Data Table on Comparison by Product
- Exhibits48: Chart on Antihistamines - Market size and forecast 2023-2028 ($ billion)
- Exhibits49: Data Table on Antihistamines - Market size and forecast 2023-2028 ($ billion)
- Exhibits50: Chart on Antihistamines - Year-over-year growth 2023-2028 (%)
- Exhibits51: Data Table on Antihistamines - Year-over-year growth 2023-2028 (%)
- Exhibits52: Chart on Intranasal corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Exhibits53: Data Table on Intranasal corticosteroids - Market size and forecast 2023-2028 ($ billion)
- Exhibits54: Chart on Intranasal corticosteroids - Year-over-year growth 2023-2028 (%)
- Exhibits55: Data Table on Intranasal corticosteroids - Year-over-year growth 2023-2028 (%)
- Exhibits56: Chart on Immunotherapies - Market size and forecast 2023-2028 ($ billion)
- Exhibits57: Data Table on Immunotherapies - Market size and forecast 2023-2028 ($ billion)
- Exhibits58: Chart on Immunotherapies - Year-over-year growth 2023-2028 (%)
- Exhibits59: Data Table on Immunotherapies - Year-over-year growth 2023-2028 (%)
- Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
- Exhibits64: Market opportunity by Product ($ billion)
- Exhibits65: Data Table on Market opportunity by Product ($ billion)
- Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
- Exhibits69: Chart on Geographic comparison
- Exhibits70: Data Table on Geographic comparison
- Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
- Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
- Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
- Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- Exhibits103: Chart on France - Market size and forecast 2023-2028 ($ billion)
- Exhibits104: Data Table on France - Market size and forecast 2023-2028 ($ billion)
- Exhibits105: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibits106: Data Table on France - Year-over-year growth 2023-2028 (%)
- Exhibits107: Market opportunity By Geographical Landscape ($ billion)
- Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
- Exhibits109: Impact of drivers and challenges in 2023 and 2028
- Exhibits110: Overview on Criticality of inputs and Factors of differentiation
- Exhibits111: Overview on factors of disruption
- Exhibits112: Impact of key risks on business
- Exhibits113: Vendors covered
- Exhibits114: Matrix on vendor position and classification
- Exhibits115: ALK Abello AS - Overview
- Exhibits116: ALK Abello AS - Product / Service
- Exhibits117: ALK Abello AS - Key offerings
- Exhibits118: Apotex Inc. - Overview
- Exhibits119: Apotex Inc. - Product / Service
- Exhibits120: Apotex Inc. - Key offerings
- Exhibits121: Bayer AG - Overview
- Exhibits122: Bayer AG - Business segments
- Exhibits123: Bayer AG - Key news
- Exhibits124: Bayer AG - Key offerings
- Exhibits125: Bayer AG - Segment focus
- Exhibits126: Dr Reddys Laboratories Ltd. - Overview
- Exhibits127: Dr Reddys Laboratories Ltd. - Business segments
- Exhibits128: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibits129: Dr Reddys Laboratories Ltd. - Segment focus
- Exhibits130: Faes Farma SA - Overview
- Exhibits131: Faes Farma SA - Product / Service
- Exhibits132: Faes Farma SA - Key offerings
- Exhibits133: GlaxoSmithKline Plc - Overview
- Exhibits134: GlaxoSmithKline Plc - Business segments
- Exhibits135: GlaxoSmithKline Plc - Key news
- Exhibits136: GlaxoSmithKline Plc - Key offerings
- Exhibits137: GlaxoSmithKline Plc - Segment focus
- Exhibits138: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibits139: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibits140: Glenmark Pharmaceuticals Ltd. - Key offerings
- Exhibits141: Haleon Plc - Overview
- Exhibits142: Haleon Plc - Business segments
- Exhibits143: Haleon Plc - Key offerings
- Exhibits144: Haleon Plc - Segment focus
- Exhibits145: Hikma Pharmaceuticals Plc - Overview
- Exhibits146: Hikma Pharmaceuticals Plc - Business segments
- Exhibits147: Hikma Pharmaceuticals Plc - Key offerings
- Exhibits148: Hikma Pharmaceuticals Plc - Segment focus
- Exhibits149: Merck and Co. Inc. - Overview
- Exhibits150: Merck and Co. Inc. - Business segments
- Exhibits151: Merck and Co. Inc. - Key news
- Exhibits152: Merck and Co. Inc. - Key offerings
- Exhibits153: Merck and Co. Inc. - Segment focus
- Exhibits154: Mitsubishi Chemical Group Corp. - Overview
- Exhibits155: Mitsubishi Chemical Group Corp. - Business segments
- Exhibits156: Mitsubishi Chemical Group Corp. - Key offerings
- Exhibits157: Mitsubishi Chemical Group Corp. - Segment focus
- Exhibits158: Novartis AG - Overview
- Exhibits159: Novartis AG - Business segments
- Exhibits160: Novartis AG - Key offerings
- Exhibits161: Novartis AG - Segment focus
- Exhibits162: Sanofi SA - Overview
- Exhibits163: Sanofi SA - Business segments
- Exhibits164: Sanofi SA - Key news
- Exhibits165: Sanofi SA - Key offerings
- Exhibits166: Sanofi SA - Segment focus
- Exhibits167: Stallergenes Greer Ltd. - Overview
- Exhibits168: Stallergenes Greer Ltd. - Product / Service
- Exhibits169: Stallergenes Greer Ltd. - Key offerings
- Exhibits170: Viatris Inc. - Overview
- Exhibits171: Viatris Inc. - Business segments
- Exhibits172: Viatris Inc. - Key news
- Exhibits173: Viatris Inc. - Key offerings
- Exhibits174: Viatris Inc. - Segment focus
- Exhibits175: Inclusions checklist
- Exhibits176: Exclusions checklist
- Exhibits177: Currency conversion rates for US$
- Exhibits178: Research methodology
- Exhibits179: Validation techniques employed for market sizing
- Exhibits180: Information sources
- Exhibits181: List of abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook